Barbara Davis Center and The Children's Hospital Colorado, University of Colorado, Aurora, CO 80045, USA.
Curr Diab Rep. 2012 Oct;12(5):510-6. doi: 10.1007/s11892-012-0303-6.
Continuing glucose monitoring (CGM) is a relatively new and rapidly developing technology that shows promise for the future management of type 1 diabetes. When used with near-daily frequency, it has a significant effect on improvement of glucose metabolism as measured by HbA1C and reduction of hypoglycemia. It appears to be safe and actually reduces both DKA and severe hypoglycemia. Early studies indicate that it should be cost effective.
持续血糖监测（CGM）是一种相对较新且快速发展的技术，有望用于未来管理 1 型糖尿病。当它被近乎每天使用时，它对 HbA1C 测量的葡萄糖代谢改善和低血糖减少有显著效果。它看起来是安全的，实际上可以减少 DKA 和严重低血糖。早期研究表明它应该具有成本效益。
